Spherix, Fullife Healthcare Sign Supply, License Pact for D-Tagatose

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

SpherixIncorporated (Nasdaq: SPEX) and Fullife Healthcare Pvt. Ltd. – aninnovation-driven company focused on bringing unique healthcare solutions toIndia – today announced the signing of a supply and license agreement for theuse of D-tagatose in nutraceutical products in India.Under the terms of the agreement, Spherix has granted Fullife an exclusive,royalty-bearing license in India for use of Spherix's clinical data andproprietary know-how to support marketing and dosing of the D-tagatose thatSpherix will also be supplying. The D-tagatose will be used in food orcosmetic products that may provide health benefits in return for a fixedroyalty on gross sales. Spherix will provide bulk D-Tagatose to Fullife andFullife will be responsible for all testing and development of productscontaining D-Tagatose for sale in India. Financial terms of the agreement werenot disclosed.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!